Search

everythinglearnresearchcommunity

for

Search:↓

Hydroxychloroquine, nitazoxanide, and ivermectin were similarly effective in treating early COVID-19.

Early treatment with certain drug combinations improved COVID-19 outcomes and prevented severe disease in males, including those at higher risk.

Men with male pattern baldness had worse COVID-19 symptoms, but early treatment with certain drugs improved outcomes for all.

Four drugs were found that could potentially treat COVID-19 by inhibiting the virus in lab tests.

Early treatment improved COVID-19 outcomes, and spironolactone helped reduce risks in females with high androgen levels.

As of December 2021, the most effective COVID-19 treatments were monoclonal antibodies and possibly early-administered convalescent plasma, while several drugs were found ineffective or were still under evaluation.

Anabolic steroid users may face higher risk of severe COVID-19.

Mint essential oils can kill parasites that cause cystic echinococcosis, with M. pulegium oil being more effective than M. piperita oil.

A blood pressure drug, diltiazem, may also help treat influenza.

Existing drug dexamethasone may lower death risk in severe COVID-19 cases; more research needed for other drugs.

Possible link between androgens and COVID-19 severity; more research needed.

COVID-19 may worsen with androgens; anti-androgen drugs could help.

Antihelminthic drugs treat worm infections but face challenges like low treatment coverage and potential drug resistance, with various side effects reported for different drugs.

Finasteride's stability and safety confirmed through precise analytical methods.

Dutasteride treatment in men with mild to moderate COVID-19 reduced viral shedding, inflammation, and recovery time without serious side effects.

The JAK/STAT pathway is important in cell processes and disease, and JAK inhibitors are promising for treating related conditions.

New nanocarriers improve drug delivery for disease treatment.

New treatments for COVID-19 show promise, but more effective antiviral drugs are needed.

Proxalutamide significantly lowered hospital admissions for male COVID-19 patients compared to a placebo.

Proxalutamide helps COVID-19 patients get rid of the virus faster and recover quicker.

Thiazole, a sulfur and nitrogen chemical, is useful in creating potential drugs for conditions like seizures, cancer, bacterial infections, tuberculosis, inflammation, malaria, viruses, Alzheimer's, diabetes, and A1-receptor issues.

Proxalutamide improved recovery, lowered death rates, and reduced hospital stay for COVID-19 patients.

Men and women get COVID-19 at similar rates, but men tend to get sicker and have a higher risk of dying, while women usually have stronger immune responses and vaccine reactions.

Hair loss is a frequent long-term effect of COVID-19, and oral minoxidil is the most common effective treatment.

Some small molecule antivirals show promise against COVID-19, but more research is needed to understand and improve them.

COVID-19 can cause hair loss, and treatments like PRP and stem cells might help.

Drug repurposing shows promise for treating many medical conditions.

Certain skin symptoms in COVID-19 patients may indicate a more severe illness.